MD Anderson awarded over $5.7 million from Break Through Cancer to support AML research

Funding is part of $20 million in grants awarded to five cancer centers for collaborative research

2023-05-16

(Press-News.org) HOUSTON – The University of Texas MD Anderson Cancer Center was awarded more than $5.7 million in grants from Break Through Cancer to support collaborative research teams working to discover novel molecular targets to eradicate minimal residual disease in acute myeloid leukemia (AML) and to treat clonal hematopoiesis, a precursor to AML.

MD Anderson received $2.7 million to fund research for the Targeting Clonal Hematopoiesis to Prevent AML TeamLab and $3 million for the Eradicating Minimal Residual Disease in AML TeamLab. The projects expand upon work initiated within MD Anderson’s Myelodysplastic Syndromes and Acute Myeloid Leukemia Moon Shot®.

This funding is part of $20 million in grants awarded to the five cancer centers that comprise Break Through Cancer: MD Anderson, Dana-Farber Cancer Institute, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, and Koch Institute for Integrative Cancer Research at MIT.

“Collaborative team research and the integration of expertise across disciplines is central to our approach at MD Anderson, and we are proud to work together across institutions to accelerate progress,” said Giulio Draetta, M.D., Ph.D., chief scientific officer at MD Anderson. “We are grateful to Break Through Cancer for supporting this important work, and we look forward to breakthroughs that can improve the lives of patients with AML.”

Draetta and David Jaffray, Ph.D., chief technology and digital officer at MD Anderson, serve as members of the Break Through Cancer Board of Directors.

The Break Through Cancer TeamLab model encourages and enables collaboration in order to look beyond conventional therapies, to develop new strategies and thinking to address challenges in cancer treatment, and to pave the way for faster discoveries. The model allows researchers to work collaboratively in real time using new technology and systems to reduce barriers that often impact cross-institutional collaboration.

The projects and faculty researchers from MD Anderson include:

Eradicating Minimal Residual Disease in AML – Researchers will investigate the mechanisms contributing to persistent residual disease after treatment and develop novel tools for detecting, targeting and treating residual AML. Contributing MD Anderson faculty researchers include: Michael Andreef, M.D., Ph.D; Pavan Bachireddy, M.D.; Jared Burks, Ph.D.; Naval Daver, M.D.; Ghayas Issa, M.D.; Priya Koppikar, Ph.D.; Jeffrey Molldrem, M.D.; Muharrem Muftuoglu, M.D.; Keyur Patel, M.D., Ph.D.; Farhad Ravandi, M.D.; and Nicholas Short, M.D. Targeting Clonal Hematopoiesis to Prevent AML – For the early detection and treatment of clonal hematopoiesis, a pre-malignant state for AML, the team will pursue novel strategies and pathways in high-risk patients. Participating MD Anderson faculty researchers include: Pavan Bachireddy, M.D.; Ken Chen, Ph.D.; Kelly Chien, M.D.; Simona Colla, Ph.D.; Courtney DiNardo, M.D.; Guillermo Garcia-Manero, M.D.; Danielle Hammond, M.D.; Jeffrey Molldrem, M.D.; and Koichi Takahashi, M.D., Ph.D. “While targeted therapies can produce dramatic responses when used in some patients with AML, standard treatments have changed little in more than 40 years,” said Jeffrey Molldrem, M.D., chair of Hematopoietic Biology and Malignancy at MD Anderson. “Two major roadblocks to improving patient outcomes are the failure of current therapies to eliminate minimal residual disease cells that have developed resistance and the lack of effective strategies to prevent the evolution of clonal hematopoiesis to AML. Gathering the top laboratory and clinical researchers at five leading institutions into focused TeamLabs will enable breakthrough discoveries that hold the promise of establishing new principles and therapeutics for our patients.”

In 2022, MD Anderson was awarded more than $10 million from Break Through Cancer to support research projects focused on pancreatic cancer, ovarian cancer and glioblastoma. Break Through Cancer launched in 2021 with the aim of bringing together the nation’s top cancer research institutions to find new solutions to some of cancer research’s biggest challenges.

END

ELSE PRESS RELEASES FROM THIS DATE:

Magnetic stimulation may improve the pain, nausea of diabetic gastroparesis

2023-05-16

AUGUSTA, Ga. (May 16, 2023) – Magnetic stimulation of a group of nerves key to how our gut and brain communicate may help correct the conversation that goes awry in painful, debilitating diabetic gastroparesis, researchers say. Patients come to Amol Sharma, MD, because their stomachs constantly hurt, they are always nauseous and they can’t or won’t eat or drink. Sometimes they can’t get out of the hospital because of nausea and vomiting. “Gastroparesis is suspected in about 2% of the population, which is the about the population of Missouri, but only confirmed in .2% ...

Genetic analysis of Indigenous Taiwanese peoples sheds light on Austronesian expansion

2023-05-16

The Austronesian language family is one of the largest in the world, comprising over 1,200 languages spoken from Madagascar to Hawaii. Dang Liu, Albert Min-Shan Ko and Mark Stoneking collected genome-wide data from 55 individuals from seven Taiwanese Austronesian groups and two Han-Taiwanese groups to study the genetic structure of Taiwan, the point of origin for all Austronesian-speaking peoples. There are over 20 different Indigenous groups in Taiwan, divided into “highland” and “lowland” peoples. Many lowland peoples have intermarried with Han people, and their languages are endangered or extinct. ...

Emissions reductions of Chinese EVs

2023-05-16

Chinese electric vehicles (EVs) drive larger emissions reductions over time, due to increased operating efficiency and a greener electricity mix, according to a study. More than 10% of Chinese car sales are now electric, but the full life cycle of EVs still creates carbon emissions. Shaojun Zhang and colleagues conducted “cradle-to-grave” life cycle assessments for EVs in 2015 and 2020, including fuel-cycle and material-cycle phases, and compiled life-cycle projections for 2030. The authors considered factors including sources of electricity, vehicle fuel economy, major automotive metals, and battery ...

Cognitive training helpful for some but not a panacea for fall prevention

2023-05-16

INDIANAPOLIS – One out of four adults, age 65 or older, falls every year in the U.S. Falls cause approximately 36,000 deaths annually in this age group, making it the leading cause of death from injury for older adults in the U.S. A new study, led by Regenstrief Institute Research Scientist Briana Sprague, PhD, examines whether cognitive training – specifically, speed of processing, memory and reasoning training -- can lower the risk of falling. Significantly, the researchers found no effects of the training on likelihood of falling for those at low risk of falling. Dr. Sprague also is a faculty member at Indiana ...

Jaw shapes of 90 shark species show: Evolution driven by habitat

2023-05-16

An international research team led by Faviel A. López-Romero of the University of Vienna investigated how the jaw shape of sharks has changed over the course of evolution. Their conclusion: in the most widespread shark species, the jaws show relatively little variation in shape over millions of years; most variable jaws were found for deep-sea sharks. The results of this study were published in the journal Communications Biology. One of the most prominent traits in sharks is the shape of their lower jaws, which bear also impressive teeth. With their jaws, sharks are able to feed on a wide variety of prey, which also places them among the Ocean's top predators. ...

NCCN Global Policy Leader named Co-Chair of Global Health Council Roundtable Advancing International Coordination in Cancer Care

2023-05-16

PLYMOUTH MEETING, PA [May 16, 2023] — The National Comprehensive Cancer Network® (NCCN®) today announced the appointment of Katy Winckworth-Prejsnar, MPH, NCCN’s Senior Manager of Global Policy and Strategic Alliances, as Co-Chair of the Global Health Council (GHC)’s Non-Communicable Diseases (NCD) Roundtable. In this role, Winckworth-Prejsnar will help drive coordination between organizations worldwide that are working to improve policy and outcomes for cancer and other global health concerns. She will serve alongside Co-Chair Eliana Monteforte, Director of Special Projects, GHC. “NCDs—including ...

Sexually active women are not judged more harshly than men

2023-05-16

Maybe you too have bought into the idea that men with numerous sexual partners are actually admired, while women with the same are condemned – the so-called sexual double standard. But that turns out to be a myth, according to a new survey. “We haven’t found that women are subjected to the traditional double standards,” says Leif Edward Ottesen Kennair, a professor at the Norwegian University of Science and Technology's (NTNU) Department of Psychology. On the contrary, men are judged a little ...

Predicting how CPR will work minutes ahead

2023-05-16

Every year, between 1,200 and 1,500 patients suffer a cardiac arrest in Norwegian hospitals. Rapid and sound treatment is absolutely essential in helping these patients survive. Even if a patient suffers a cardiac arrest within the hospital's four walls, the prognosis is poor. Only one in four survives. However, a new study suggests that easily available informaiton from the patient's own ECG could change the outcome. Treatment the same for everyone When a heart stops, doctors have to hurry, and the life-saving effort can last a long time. But doctors rarely have a good idea of what the ...

BGI Genomics advances precision medicine in Argentina, Brazil and Chile

2023-05-16

BGI Genomics recently joined a mission business to South America in April 2023. Given that this continent ranks fourth in area and fifth in population worldwide, the economic and healthcare enhancement potential of this continent is compelling. Every South American country faces different healthcare challenges and priorities. Still, the promise of precision medicine is clear: It offers an opportunity to shift the delivery of care from a legacy one-size-fits-all approach to applying the right treatment for the right patient at the right time. To help deliver on precision medicine's potential, BGI Genomics considers genetic ...

Endocrine Society’s new Scientific Statement identifies research gaps in pediatric, LGBTQIA care

2023-05-16

WASHINGTON—In a new Scientific Statement released today, the Endocrine Society identifies areas for future endocrine research to reduce health disparities in pediatric and sexual and gender minoritized populations. This Scientific Statement expands the Society’s 2012 statement by focusing on endocrine disease disparities in the pediatric and sexual and gender minoritized populations. These include pediatric and adult lesbian, gay, bisexual, transgender, queer, intersex and asexual (LGBTQIA) people. The writing group focused on prevalent conditions such as growth disorders, puberty disorders, ...

MD Anderson awarded over $5.7 million from Break Through Cancer to support AML research

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: